Arca
Skip to content
Tools
Tools

Dravet syndrome

Drug research and approvals for dravet syndrome: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 21, 2026, 14 studies of dravet syndrome are recruiting on ClinicalTrials.gov, Health Canada has authorized 12 drug trials for it since 2013, FDA has 8 approved and 17 open orphan designations naming it, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 14
  • Trials authorized in Canada: 12
  • FDA orphan approvals: 8
  • EU medicines: 2

Recruiting now

Newest posted first, of 14 recruiting on ClinicalTrials.gov ↗

Trials authorized in Canada

The 10 newest of 12; search them all in Canada trials
Oct 28, 2026Endeavor: a clinical study to evaluate the safety and efficacy of ETX101, an AAV9-delivered gene therapy in infants and children with SCN1A-positive Dravet…ETX101Encoded Therapeutics, Inc.Pending
Mar 4, 2026Phase 1-2, open-label, single and multiple ascending dose study to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of…ION337Ionis PharmaceuticalsOngoing
Jan 30, 2025A phase 3, randomized, double-blind, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of…Bexicaserin (LP352)Longboard PharmaceuticalsOngoing
May 25, 2022Fenfluramine for the treatment of refractory epilepsy in adult Dravet patientsFenfluramineUniversity Health NetworkPending
Mar 22, 2022A phase 3, prospective, open-label, multisite, extension of phase 3 studies to assess the long-term safety and tolerability of soticlestat as adjunctive…Soticlestat (TAK-935)Takeda Pharmaceuticals USAClosed
Jul 30, 2021A 20-week multicenter, randomized, double-blind, placebo-controlled trial of EPX-100 (clemizole hydrochloride) as adjunctive therapy in children and adult…Clemizole (EPX-100)Epygenix Therapeutics, Inc.Ongoing
Jul 29, 2021A multicenter, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy, safety, and tolerability of soticlestat as…Soticlestat (TAK-935)Takeda Pharmaceuticals USAClosed
May 13, 2021Extended access program and retrospective chart review for lorcaserin in Dravet syndrome and other refractory epilepsiesLorcaserinEisaiClosed
Dec 22, 2020A multicenter, double-blind, randomized, placebo-controlled, parallel-group study with open-label extension phase of lorcaserin as adjunctive treatment in…LorcaserinEisaiClosed
Nov 20, 2019An open-label extension trial to assess the long-term safety of ZX008 (fenfluramine hydrochloride) oral solution as an adjunctive therapy for seizures in…Fenfluramine (ZX008)Zogenix International LimitedClosed

FDA orphan designations

Approved first, then open designations, newest first; 15 of 25
Jul 14, 2022DiacomitTreatment of seizures associated with Dravet syndrome (DS) in patients taking clobazam who are 6 months of age and older and weighing 7 kg…BiocodexApproved
Jul 31, 2020EpidiolexTreatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients…Jazz Pharmaceuticals Research UK LimitedApproved
Jul 31, 2020EpidiolexTreatment of seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, or tuberous sclerosis complex (TSC) in patients 1 year of…Jazz Pharmaceuticals Research UK LimitedApproved
Jul 31, 2020EpidiolexTreatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC) in patients…Jazz Pharmaceuticals Research UK LimitedApproved
Jun 25, 2020FinteplaFintepla (fenfluramine) is indicated for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.UCB, Inc.Approved
Sep 28, 2018EpidiolexEPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2…Jazz Pharmaceuticals Research UK LimitedApproved
Sep 28, 2018EpidiolexEPIDIOLEX is indicated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome (DS) in patients 2…Jazz Pharmaceuticals Research UK LimitedApproved
Aug 20, 2018DiacomitDIACOMIT is indicated for the treatment of seizures associated with Dravet syndrome (DS) in patients 2 years of age and older taking…BiocodexApproved
Oct 22, 202615-base residue modified antisense oligonucleotide (ASO)…Treatment of Dravet syndromeIonis PharmaceuticalsDesignated
Apr 16, 2025Chemically modified oligonucleotide designed as an…Treatment of Dravet syndromeRecoRNA (Guangzhou) Biotechnology Co., Ltd.Designated
Jan 16, 2025(R)-N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamideTreatment of Dravet syndromeiQure Pharma IncDesignated
Sep 17, 2024Bexicaserin hydrochloride (bexicaserin)Treatment of Dravet syndromeLongboard Pharmaceuticals, Inc.Designated
Jul 27, 2022Small molecule agonist of 5-hydroxytryptamine serotonergic…Treatment of Dravet SyndromeXenon Pharmaceuticals Inc.Designated
Oct 12, 20212-[(3-Methylbutyl)amino]-1,4-naphthalenedioneTreatment of Dravet SyndromeNeuroene TherapeuticsDesignated
Aug 31, 2020LorcaserinTreatment of Dravet syndromeEisai Inc.Designated

Medicines authorised in the EU

Newest first
Dec 18, 2020FinteplaFenfluramine · orphanUCB Pharma S.A.EMA ↗
Sep 19, 2019EpidyolexCannabidiol · orphanJazz Pharmaceuticals Ireland LimitedEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.